Can beta-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction?
Faxon
David P
DP
Section of Cardiology at the University of Chicago, IL, USA. dfaxon@medicine.bsd.uchicago.edu
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D013318:Stroke Volume / Q000187:drug effects / Q000502:physiology*; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists